Home

Atlas Venture Fund XI, 10% Owner: Xilio Therapeutics XLO Sell · Filed 24/01/16

Trade details

Type
Insider sale
Amount
$1,362.42
Shares · price
1,566 sh · $0.87 a share
Held after
2,021,836 sh
Trade date
24/01/11
Filed
24/01/16
Days to filing
5 days

Sold 0.1% of holdings

Share of holding sold
0.1%

Xilio Therapeutics trades, last 26 weeks

What else happened in Xilio Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/12~24/02/10

Atlas Venture Fund XI's recent trades

  • Atlas Venture Fund XI

    Planned sale10b5-1 planKorro Bio

    $440.4K

    Filed 09/14

  • Atlas Venture Fund XI

    Planned sale10b5-1 planKorro Bio

    $110.4K

    Filed 09/11

  • Atlas Venture Fund XI

    Planned sale10b5-1 planKorro Bio

    $3,419

    Filed 08/26

  • Atlas Venture Fund XI

    Planned sale10b5-1 planKorro Bio

    $311.8K

    Filed 08/19

  • Atlas Venture Fund XI

    Planned sale10b5-1 planDyne Therapeutics

    $35.3M

    Filed 08/14